# FDA Inspection 981303 - Kaysersberg Pharmaceuticals SAS - July 19, 2016

Source: https://www.keypedia.com/records/fda_inspections/kaysersberg-pharmaceuticals-sas/107d2a0c-87ae-4a0f-95a0-14a5eb7bcbc2
Source feed: FDA_Inspections

> FDA Inspection 981303 for Kaysersberg Pharmaceuticals SAS on July 19, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 981303
- Company Name: Kaysersberg Pharmaceuticals SAS
- Inspection Date: 2016-07-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1268813 - 2024-05-17](https://www.keypedia.com/records/fda_inspections/kaysersberg-pharmaceuticals-sas/095ff042-df17-4d35-9ebc-789a3322bd1b)
- [FDA Inspection 1123773 - 2019-02-01](https://www.keypedia.com/records/fda_inspections/kaysersberg-pharmaceuticals-sas/463eba5d-a350-4378-b395-506f5abe1fb0)
- [FDA Inspection 661210 - 2010-04-19](https://www.keypedia.com/records/fda_inspections/kaysersberg-pharmaceuticals-sas/f7143227-32c0-41db-a06d-939c313901db)

Company: https://www.keypedia.com/companies/kaysersberg-pharmaceuticals-sas/4f0bba88-dadd-49db-8e17-08165e705377

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c